{"id":4925,"date":"2019-03-18T10:04:11","date_gmt":"2019-03-18T10:04:11","guid":{"rendered":"https:\/\/primaderma.ro\/2019\/?page_id=4925"},"modified":"2019-04-02T09:19:54","modified_gmt":"2019-04-02T09:19:54","slug":"sef-lucr-dr-branisteanu-daniel-constantin","status":"publish","type":"page","link":"https:\/\/pdi.ro\/2019\/sef-lucr-dr-branisteanu-daniel-constantin\/","title":{"rendered":"\u015eef Lucr. Dr. Br\u0103ni\u0219teanu Daniel Constantin"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; disabled_on=&#8221;on|off|off&#8221; _builder_version=&#8221;3.19.4&#8243; custom_margin=&#8221;||&#8221; custom_padding=&#8221;15px||29px&#8221; top_divider_style=&#8221;waves2&#8243; top_divider_color=&#8221;#f0622a&#8221; top_divider_flip=&#8221;horizontal|vertical&#8221; bottom_divider_style=&#8221;waves2&#8243; bottom_divider_color=&#8221;#fcdedb&#8221; bottom_divider_height=&#8221;105px&#8221; bottom_divider_flip=&#8221;vertical&#8221; collapsed=&#8221;off&#8221;][et_pb_fullwidth_header title=&#8221;{%22dynamic%22:true,%22content%22:%22post_title%22,%22settings%22:{%22before%22:%22%22,%22after%22:%22%22}}&#8221; text_orientation=&#8221;right&#8221; header_image_url=&#8221;https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/01\/Primaderma2019_logo_300px.png&#8221; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;3.19.4&#8243; _dynamic_attributes=&#8221;title&#8221; title_font=&#8221;Kaushan Script||||||||&#8221; title_text_align=&#8221;right&#8221; title_text_color=&#8221;#f0622a&#8221; title_font_size=&#8221;50px&#8221; content_font=&#8221;|600||on|||||&#8221; content_text_align=&#8221;center&#8221; content_text_color=&#8221;#686766&#8243; content_font_size=&#8221;15px&#8221; content_font_size_phone=&#8221;15px&#8221; content_font_size_last_edited=&#8221;on|desktop&#8221; subhead_font=&#8221;||||||||&#8221; background_color=&#8221;rgba(239,145,107,0.54)&#8221; background_image=&#8221;https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/01\/back.jpg&#8221; background_layout=&#8221;light&#8221; custom_margin=&#8221;0px||8px&#8221; custom_padding=&#8221;40px||40px||true&#8221;][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.19.18&#8243;][et_pb_row _builder_version=&#8221;3.19.18&#8243;][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;3.19.18&#8243;][et_pb_image src=&#8221;https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/03\/BranisteanuDaniel.png&#8221; align=&#8221;center&#8221; _builder_version=&#8221;3.19.18&#8243; border_radii=&#8221;on|100px|100px|100px|100px&#8221; max_width=&#8221;31%&#8221;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;3.19.18&#8243;][et_pb_text _builder_version=&#8221;3.19.18&#8243;]<\/p>\n<h4><strong><span style=\"color: #ff9900;\"><\/span><\/strong><\/h4>\n<h4><strong><span style=\"color: #ff9900;\"><\/span><\/strong><\/h4>\n<h4><strong><span style=\"color: #ff9900;\"><\/span><\/strong><\/h4>\n<h4><strong><span style=\"color: #ff9900;\"><\/span><\/strong><\/h4>\n<h4><strong><span style=\"color: #ff9900;\">\u015eef Lucr. Dr.\u00a0Br\u0103ni\u0219teanu Daniel Constantin<\/span><\/strong><br \/><strong><span style=\"color: #ff9900;\"> Universitatea de Medicin\u0103 \u0219i Farmacie &#8220;Grigore T. Popa\u201d Ia\u0219i<\/span><\/strong><\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;3.19.18&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;3.19.18&#8243;][et_pb_text _builder_version=&#8221;3.19.18&#8243;]<\/p>\n<p><!--<\/p>\n\n\n\n\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\"><strong>Pemfigoidul cicatricial ocular<\/strong><\/span><\/p>\n\n\n\n\n<p><span style=\"color: #ff6600;\"> Autori: Daniel Constantin Br\u0103ni\u015fteanu, C\u0103t\u0103lina Ioana Br\u0103ni\u015fteanu, Andrei B\u00eelha<\/span><\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Pemfigoidul cicatricial ocular (PCO) este o afec\u021biune rar\u0103, de etiologie autoimun\u0103, cronic\u0103, asimetric\u0103 \u0219i bilateral\u0103, ce poate fi responsabil\u0103 de sc\u0103derea irecuperabil\u0103 a acuit\u0103\u021bii vizuale \u00een cazurile severe. PCO se \u00eent\u00e2lne\u0219te frecvent la pacien\u021bii ce sufer\u0103 de pemfigoid, o boal\u0103 autoimun\u0103 cronic\u0103. Prezentarea \u00ee\u0219i propune s\u0103 realizeze o punere la punct \u00een conformitate cu ultimele informa\u021bii legate de epidemiologie, diagnostic \u0219i tratament al PCO, facilit\u00e2nd astfel un diagnostic precoce, \u00een stadiile incipiente \u0219i rezultate terapeutice superioare.<\/p>\n\n\n\n\n<p>Deoarece PCO este o patologie rar\u0103, diagnosticul \u00een stadiile precoce este rareori realizat. Prevalen\u021ba PCO este dificil de estimat \u00eentruc\u00e2t datele din literatur\u0103 variaz\u0103 \u00eentre 1 caz la 8.000 - 45.000 de indivizi, cu un raport femei\/b\u0103rba\u021bi de 2\/1. Efectuarea unei anamneze corecte este foarte important\u0103 \u00een stabilirea diagnosticului. Trebuie eliminate din antecedentele personale patologice traumatismele, arsurile chimice \u0219i sindromul Steven\u2019s Johnson. Examinarea clinic\u0103 exhaustiv\u0103 este obligatorie, inclusiv examinarea atent\u0103 a mucoaselor \u0219i tegumentului.<\/p>\n\n\n\n\n<p>Diagnosticul de PCO este suspicionat atunci c\u00e2nd examinarea oftalmologic\u0103 biomicroscopic\u0103 eviden\u021biaz\u0103 semne de fibroz\u0103 \u0219i cicatrici conjunctivale, scurtarea fornixului, apari\u021bia simblefaronul sau anchiloblefaronul, de cauz\u0103 aparent necunoscut\u0103.<\/p>\n\n\n\n\n<p>Testele diagnostice, \u00een special cele serologice, au rolul de a \u00eenl\u0103tura alte cauze de fibroz\u0103 subconjunctival\u0103 de etiologie sistemic\u0103. Radiografiile toracice sau CT-ul toracic exclud sarcoidoza. Suspiciunea de sindrom paraneoplazic trebuie, de asemenea, \u00eenl\u0103turat\u0103. Imunofluorescen\u021ba direct\u0103 pozitiv\u0103 pe fragmentul ob\u021binut \u00een urma biopsiei confirm\u0103 diagnosticul, dar nepozitivarea probei nu exclude diagnosticul.<\/p>\n\n\n\n\n<p>Sistemele de stadializare Foster (bazat pe semnele clinice) si Mondino si Brown (bazat pe profunzimea fornixului inferior) reprezint\u0103 metode obiective de evaluare a PCO oferind suport \u00een urm\u0103rirea progresiei bolii.<\/p>\n\n\n\n\n<p>Scopul terapiei este reprezentat de controlul inflama\u021biei \u0219i supresia procesului fibrotic. Arsenalul terapeutic este vast \u0219i \u00een func\u021bie de severitatea cazului variaz\u0103 de la medica\u021bie topic\u0103 la imunosupresie sistemic\u0103. \u00cen stadiile avansate ale bolii este adesea necesar\u0103 chirurgia complica\u021biilor oculare.<\/p>\n\n\n\n\n<p>Prognosticul CPO este rezervat datorit\u0103 progresiei naturale c\u0103tre complica\u021bii corneene severe \u00een 30% dintre cazuri. De aceea, pacien\u021bii cu CPO necesit\u0103 evalu\u0103ri oftalmologice periodice, \u201cinflama\u021bia alb\u0103\u201d fiind frecvent \u00eent\u00e2lnit\u0103. Mai mult dec\u00e2t at\u00e2t, to\u021bi pacien\u021bii cu pemfigoid trebuie s\u0103 beneficieze de examin\u0103ri oftalmologice minu\u021bioase, pentru a depista modific\u0103rile patologice conjuctivale precoce.<\/p>\n\n\n\n\n<p><img decoding=\"async\" src=\"https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/03\/poze_Branisteanu.png\" align=\"left\" \/><\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Figura 1. Tegument palpebral \u00eengro\u0219at. Simblefaron.<\/p>\n\n\n\n\n<p>Madarosis la nivelul pleoapei superioare.<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\"><strong>Ocular cicatricial pemphigoid<\/strong><\/span><\/p>\n\n\n\n\n<p><span style=\"color: #ff6600;\"> Authors: Daniel Constantin Br\u0103ni\u015fteanu, C\u0103t\u0103lina Ioana Br\u0103ni\u015fteanu, Andrei B\u00eelha<\/span><\/p>\n\n\n\n\n<p style=\"text-align: justify;\">Ocular cicatricial pemphigoid (OCP) is a bilateral, asymmetric, autoimmune chronic disorder of uncommon prevalence, responsible for irreversible visual loss in cases of severe involvement. OCP is a common occurrence in patients with mucous membrane pemphigoid, a chronic systemic autoimmune disease. Therefore, this presentation aims to review the latest information regarding the epidemiology, diagnosis and treatment of OCP, facilitating an early diagnosis and better treatment results.<\/p>\n\n\n\n\n<p>Although a rare disease, OCP is considered to be frequently underdiagnosed especially in its early stages. The prevalence is difficult to estimate as literature data on this topic varies between 1 in 8.000 to 45.000 individuals, with a female\/male ratio of 2\/1. Assessing the patient\u2019s history is crucial for diagnosis. Ocular conditions like trauma, chemical burns or Steven\u2019s Johnson Syndrome have to be ruled out on the spot. A comprehensive clinical examination is mandatory, including a careful examination of the skin and mucosae.<\/p>\n\n\n\n\n<p>OCP has to be suspected when slit-lamp examination reveals subconjunctival scarring and fibrosis, fornix shortening, symblepharon or ankyloblepharon of unknown cause.<\/p>\n\n\n\n\n<p>The diagnostic workup aims to rule out other systemic causes of conjunctival scarring. Serological tests are performed. In addition to these, additional evaluations such as chest x-rays or CT scans are required in order to exclude sarcoidosis. Paraneoplastic disorders should also be excluded. At the end, a diagnosis of OCP has to be considered. While positive direct immunofluorescence on biopsy confirms diagnosis, a negative biopsy cannot exclude the diagnosis of OCP.<\/p>\n\n\n\n\n<p>The Foster staging system (based on clinical signs) and Mondino and Brown system (based on the inferior fornix depth) are powerful tools for OCP grading, thus offering support in assessing staging and progression.<\/p>\n\n\n\n\n<p>The main targets of therapy are inflammation control and suppression of the fibrotic processes. The current medical treatment varies from topical drugs to systemic immunosuppression. Surgical procedures are often warranting in advanced stages of the disease.<\/p>\n\n\n\n\n<p>In terms of prognosis, OCP progresses to blindness in up to 30% of patients due to corneal complications. Thus, all OCP patients require permanent evaluations, even in the absence of a red eye, as \u201cwhite inflammation\u201d is a common feature. Moreover, na\u00efve patients with mucous membrane pemphigoid must benefit of careful ophthalmic evaluation in order to investigate the presence of conjunctival abnormalities.<\/p>\n\n\n\n\n<p><img decoding=\"async\" src=\"https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/03\/poze_Branisteanu.png\" align=\"left\" \/><\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p>&nbsp;<\/p>\n\n\n\n\n<p style=\"text-align: justify;\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Figure 1. Thickened eyelids. Symblepharon.<\/p>\n\n\n\n\n<p>Madarosis of the superior lid.<\/p>\n\n\n\n\n<p>--><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\">Manifest\u0103ri oculare \u00een infec\u021biile virale cutanate<\/span><br \/> <span style=\"color: #ff6600;\"> Autori: Daniel Constantin Br\u0103ni\u015fteanu, C\u0103t\u0103lina Ioana Br\u0103ni\u015fteanu, Andrei B\u00eelha<\/span><\/p>\n<p style=\"text-align: justify;\">Multipli agenti patogeni virali determin\u0103 afectare dubla cutanat\u0103 \u0219i ocular\u0103.<br \/> <strong>Herpesul ocular<\/strong>. Boala herpetic\u0103 ocular\u0103 este o cauz\u0103 frecvent\u0103 de orbire \u00een \u021b\u0103rile subdezvoltate. Cea mai frecvent\u0103 manifestare ocular\u0103 dat\u0103 de HSV este keratita herpetic\u0103 superficiala, ce \u00eensumeaz\u0103 aproximativ 80% din totalul afect\u0103rilor oculare cauzate de HSV. Pacien\u021bii cu keratit\u0103 herpetic\u0103 superficiala prezint\u0103 ochi rosu dureros, acuitate vizual\u0103 sc\u0103zut\u0103, fotofobie, l\u0103crimare. Examenul biomicroscopic evidentiaza leziuni corneene ulcerative cu aspect dendritic (figura 1), punctiform sau geografic, pozitive la testul cu fluorescein\u0103 sau roz Bengal. Sensibilitatea cornean\u0103 este redus\u0103.<br \/> <strong>Zona zoster oftalmic\u0103<\/strong>. Manifest\u0103rile clinice caracteristice zonei zoster oftalmice sunt reprezentate de leziuni veziculare dureroase la nivelul tegumentului dermatomului afectat, iar semnul Hutchinson (interesarea aripii sau bazei nasului) avertizeaza asupra iminentei afect\u0103ri oculare, cel mai frecvent corneana.<br \/> Infec\u021biile oculare datorate virusului Papiloma uman. Sunt afectate frecvent conjunctiva (papiloame) dar si suprafa\u021ba ocular\u0103 (pterigion, papilomul scuamos conjunctival, neoplazia intraepitelial\u0103 conjunctival\u0103 \u0219i neoplazia scuamoas\u0103 a suprafetei oculare).<br \/> <strong>Conjunctivita viral\u0103<\/strong>. Este cel mai frecvent produsa de adenovirus si se manifesta prin disconfort local important, congestie conjunctivala moderat\u0103 sau sever\u0103 si secretie apoasa. Fotofobia si scaderea acuitatii vizuale sunt consecinta afectarii corneene (cheratoconjunctivita epidemic\u0103). Infiltratele subepiteliale corneene pot avea un impact negativ asupra functiei vizuale pe termen lung si permit diagnosticul retrospectiv. Rash-ul cutanat asociat apare \u00een special la pacien\u021bii imunodeprima\u021bi.<br \/> <strong>Molluscum contagiosum<\/strong>. Leziunile de tip nodular sunt cel mai frecvent localizate la nivelul pleoapelor. \u00cen general evolu\u021bia lor este benign\u0103, cu remisiunea spontana intr-o perioad\u0103 de 6-18 luni de zile. Conjunctivita foliculara cronica este consecinta reactiei antigenice sau toxice de la nivelul filmului lacrimal indusa de proteina virala.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/03\/poze_Branisteanu-manifestari.png\" align=\"left\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Fig1. Cheratit\u0103 herpetic\u0103 superficial\u0103 pe grefon cornean.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\">Ocular manifestations of viral skin diseases<\/span><br \/> <span style=\"color: #ff6600;\">Authors: Daniel Constantin Br\u0103ni\u015fteanu, C\u0103t\u0103lina Ioana Br\u0103ni\u015fteanu, Andrei B\u00eelha<\/span><\/p>\n<p style=\"text-align: justify;\">Many viral pathogens are responsible for both skin and ocular involvement.<br \/> <strong>Ocular herpes<\/strong>. Eye herpes, also known as ocular herpes, is still a leading cause of blindness in underdeveloped countries. The most frequent ocular manifestation (80%) of herpes simplex virus (HSV) infection is the superficial keratitis. Patients with herpes simplex keratitis have a red, painful eye with decreased vision, photophobia and tearing. Slit lamp examination reveals typical dendritic or punctate corneal ulcerations better seen on Bengal rose or fluorescein test. The corneal sensitivity is decreased.<br \/> <strong>Herpes Zoster Ophthalmicus<\/strong>. The clinical features of herpes zoster ophthalmicus include dermatomal forehead rash and painful inflammation. The Hutchinson sign (vesicles appearance on the tip or on the side of the nose) predicts the corneal involvement by the ophthalmic herpes zoster.<br \/> Ocular Human Papillomavirus Infections. Most frequently ocular involvement is represented by conjunctival squamous papilloma. Ocular surface squamous neoplasia, a spectrum of lesions of the cornea and conjunctiva derived from squamous epithelium, ranging from low-grade dysplasia to invasive squamous carcinoma, might also be related to HPV infection.<br \/> <strong>Viral Conjunctivitis<\/strong>. Is most frequently related to adenovirus infection, and the main ocular symptoms include moderate to severe conjunctival hyperemia, itching and excessive tearing. Decreased vision and photophobia are the consequence of corneal involvement (Adenoviral Keratoconjunctivitis). Adenoviral corneal opacities can impact visual acuity on medium or long term and also allow a retrospective diagnosis. An associated skin rash can be seen in immunocompromised persons.<br \/> <strong>Molluscum contagiosum<\/strong>. Often is responsible for nodular, typical lesions on the eyelids that spontaneously disappear within 6-18 months. Chronic follicular conjunctivitis reflects the antigenic reactions induced by the presence of viral protein into tears.<br \/> <img decoding=\"async\" src=\"https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/03\/poze_Branisteanu-manifestari.png\" align=\"left\" \/><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Fig1. Recurrent herpes simplex keratitis on corneal graft.<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\"><\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff9900;\">Scurt CV<\/span><\/p>\n<p style=\"text-align: justify;\"><strong>Titluri profesionale:<\/strong><br \/> \u2022 Sef de Lucr\u0103ri \u0219i Titular de Curs la Disciplina Oftalmologie a Universit\u0103\u021bii de Medicin\u0103 \u0219i Farmacie \u201eGrigore T.Popa\u201d Ia\u0219i,<br \/> \u2022 Specialist \u00een Retinologie, Seful Clinicii \u201eRETINA CENTER\u201d Iasi, Rom\u00e2nia<br \/> \u2022 Membru fondator \u0219i membru \u00een Comitetul de Conducere a Societ\u0103\u021bii Romane RETINA;<br \/> \u2022 Membru \u00een Consiliul de conducere a Societ\u0103\u021bii Rom\u00e2ne de Oftalmologie;<br \/> \u2022 Titlu onorific de FEBO (Fellow of the European Board of Ophthalmology) acordat \u00een 2014 pentru merite profesionale \u0219i contribu\u021bia adus\u0103 \u0219colii de retinologie rom\u00e2ne\u0219ti;<br \/> \u2022 Editor Asistent si membru in Comitetul Editorial National al \u201cRomanian Journal of Ophthalmology\u201d;<br \/> \u2022 Membru EURETINA (European Society of Retina Specialists);<\/p>\n<p style=\"text-align: justify;\"><strong>Calific\u0103ri:<\/strong><br \/> \uf0fc Titlu de Doctor Medic a Universit\u0103\u021bii de Medicin\u0103 si Farmacie \u201eGrigore T.Popa\u201d Iasi, 1991<br \/> \uf0fc AFSA \u00een oftalmologie, specializarea retin\u0103, la Universitatea Claude Bernard, Lyon, France;<br \/> \uf0fc Medic primar oftalmolog din 2000;<br \/> \uf0fc Doctor \u00een \u0218tiin\u021be Medicale din 2006 datorit\u0103 Lucr\u0103rii \u00een Retinologie;<br \/> \uf0fc Stagii de preg\u0103tire \u00een patologia medical\u0103 \u0219i chirurgical\u0103 a retinei \u00een departamente de specialitate din Lyon, Fran\u021ba; Louisville, SUA; Gent, Belgia; Frankfurt, Berlin si Wurzburg, Germania;<\/p>\n<p style=\"text-align: justify;\"><strong>Contribu\u021bii \u0219tiin\u021bifice \u0219i profesionale:<\/strong><br \/> \u2022 Crearea primului centru de retin\u0103 medical\u0103, laser \u0219i chirurgical\u0103 \u00eentr-un spital public din zona Moldovei in 1997;<br \/> \u2022 Implicarea constant\u0103 \u00een promovarea \u0219i implementarea de noi metode diagnostice, tratamente medicale \u0219i chirurgicale \u00een patologia retinei;<br \/> \u2022 Cooperare \u0219tiin\u021bific\u0103 \u0219i implicare activ\u0103 \u00een 7 studii clinice interna\u021bionale;<br \/> \u2022 Peste 50 de articole \u0219i capitole de carte publicate;<br \/> \u2022 Peste 150 de prezent\u0103ri \u0219tiin\u021bifice la Congrese Na\u021bionale \u0219i Interna\u021bionale;<br \/> \u2022 Speaker invitat la Conferin\u021be \u0219i Congrese de specialitate;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;3.19.4&#8243; background_color=&#8221;rgba(117,194,33,0.23)&#8221; background_image=&#8221;https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/01\/back_justflowers_overlay1.png&#8221; background_blend=&#8221;luminosity&#8221; custom_padding=&#8221;54px|0px|0|0px|false|false&#8221; top_divider_style=&#8221;waves2&#8243; top_divider_color=&#8221;#ffffff&#8221; top_divider_height=&#8221;155px&#8221; bottom_divider_style=&#8221;waves2&#8243; bottom_divider_color=&#8221;#75c221&#8243; bottom_divider_flip=&#8221;vertical&#8221;][et_pb_row custom_padding=&#8221;61px|0px|69px|0px|false|false&#8221; _builder_version=&#8221;3.18.9&#8243;][et_pb_column type=&#8221;3_5&#8243; _builder_version=&#8221;3.18.9&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_font=&#8221;Kaushan Script||||||||&#8221; text_text_color=&#8221;#f0622a&#8221; text_font_size=&#8221;30px&#8221; header_font=&#8221;||||||||&#8221; background_layout=&#8221;dark&#8221;]<\/p>\n<p>Contacteaz\u0103 operatorul PDI 2019<\/p>\n<p>[\/et_pb_text][et_pb_contact_form email=&#8221;contact@pdi.ro\/2019&#8243; submit_button_text=&#8221;Trimite mesajul&#8221; _builder_version=&#8221;3.19.4&#8243; title_font=&#8221;||||||||&#8221;][et_pb_contact_field field_id=&#8221;Name&#8221; field_title=&#8221;Nume&#8221; _builder_version=&#8221;3.18.9&#8243; border_radii=&#8221;on||||&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_contact_field][et_pb_contact_field field_id=&#8221;Email&#8221; field_title=&#8221;Adresa de e-mail&#8221; field_type=&#8221;email&#8221; _builder_version=&#8221;3.19.4&#8243; border_radii=&#8221;on||||&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_contact_field][et_pb_contact_field field_id=&#8221;Message&#8221; field_title=&#8221;Mesajul dvs.&#8221; field_type=&#8221;text&#8221; fullwidth_field=&#8221;on&#8221; _builder_version=&#8221;3.18.9&#8243; border_radii=&#8221;on||||&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][et_pb_column type=&#8221;2_5&#8243; _builder_version=&#8221;3.18.9&#8243;][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_font=&#8221;Kaushan Script||||||||&#8221; text_text_color=&#8221;#f0622a&#8221; text_font_size=&#8221;30px&#8221; header_font=&#8221;||||||||&#8221; background_layout=&#8221;dark&#8221;]<\/p>\n<p>Operatorul PDI 2019<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;3.19.4&#8243; text_font=&#8221;||||||||&#8221;]<span><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pdi.ro\/2019\/wp-content\/uploads\/2019\/01\/eventer_logo_150px.png\" width=\"151\" height=\"33\" alt=\"\" class=\"wp-image-774 alignleft size-full\" \/><\/span><\/p>\n<p><span><\/span><\/p>\n<p><span><\/span><\/p>\n<p><span>Adresa: Str. A. Panu nr. 13, Iasi<\/span><br \/>\n<span>Tel.: 0332.40.88.00-05<\/span><br \/>\n<span>E-mail: <a href=\"mailto:inscrieri@pdi.ro\/2019\" target=\"_blank\" rel=\"noopener noreferrer\">inscrieri@pdi.ro\/2019<\/a><br \/>\n<\/span><span>Website:\u00a0<\/span><a href=\"http:\/\/www.eventernet.ro\/\" target=\"Blank\" rel=\"noopener noreferrer\">www.eventernet.ro<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u015eef Lucr. Dr.\u00a0Br\u0103ni\u0219teanu Daniel Constantin Universitatea de Medicin\u0103 \u0219i Farmacie &#8220;Grigore T. Popa\u201d Ia\u0219i Manifest\u0103ri oculare \u00een infec\u021biile virale cutanate Autori: Daniel Constantin Br\u0103ni\u015fteanu, C\u0103t\u0103lina Ioana Br\u0103ni\u015fteanu, Andrei B\u00eelha Multipli agenti patogeni virali determin\u0103 afectare dubla cutanat\u0103 \u0219i ocular\u0103. Herpesul ocular. Boala herpetic\u0103 ocular\u0103 este o cauz\u0103 frecvent\u0103 de orbire \u00een \u021b\u0103rile subdezvoltate. Cea mai [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"class_list":["post-4925","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/pages\/4925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/comments?post=4925"}],"version-history":[{"count":8,"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/pages\/4925\/revisions"}],"predecessor-version":[{"id":5378,"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/pages\/4925\/revisions\/5378"}],"wp:attachment":[{"href":"https:\/\/pdi.ro\/2019\/wp-json\/wp\/v2\/media?parent=4925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}